主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CALC
#3867
CalciMedica, Inc. Common Stock
0.5
2
-7.14%
版块:
基础:
利润货币:
日范围
年范围
日变化
-7.14%
每月变动
-38.10%
6个月变化
-82.07%
年变化
-78.78%
前一天收盘价
0.5
6
Open
0.5
2
Bid
Ask
Low
0.5
2
High
0.5
2
交易量
4
市场
股票
医疗保健
CALC
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
1.5 M
1.53 M
1.57 M
10.74 M
13.48 M
—
Valuation ratios
Enterprise value
—
—
—
27.39 M
39.79 M
—
Price to earnings ratio
—
—
—
-0.4
-2.9
-6.89
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
—
—
—
0.53
1.88
5.89
Price to book ratio
—
—
—
1.69
2.76
4.96
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.27
-0.52
-0.9
-2.82
-0.69
-1.25
Return on equity %
-0.29
-0.55
-0.99
-4.21
-0.95
-30.85
Return on invested capital %
-1 588.65
-2 042.52
-3 529.04
-9 642.06
-9 496.42
-12.38 K
Gross margin %
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
14.18
16.53
10.72
2.88
5.34
20.48
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
—
—
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
0
—
—
Long term debt to total equity ratio
—
—
—
0
—
—
Per share metrics
Operating cash flow per share
—
—
-14.91
-5.74
-1.88
-1.57
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
—
25.49
2.5
1.66
5.6
Net current asset value per share
—
—
25.84
2.59
1.75
5.84
Tangible book value per share
—
—
23.43
1.82
1.28
2.45
Working capital per share
—
—
23.43
1.69
1.42
4.71
Book value per share
—
—
23.43
1.82
1.28
2.45
新闻
H.C. Wainwright将CalciMedica股票评级下调至中性,因试验暂停
CalciMedica stock downgraded to Neutral by H.C. Wainwright after trial halt
CalciMedica因委员会建议终止二期KOURAGE临床试验
CalciMedica discontinues Phase 2 KOURAGE trial following committee recommendation
U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.02%
美国股市涨跌不一;截至收盘道琼斯工业平均指数上涨0.02%
CalciMedica股价因终止肾损伤试验而暴跌
CalciMedica因安全担忧终止急性肾损伤试验
CalciMedica discontinues AKI trial following safety concerns
CalciMedica Pauses Kidney Study, Eyes New Trial In Pancreatitis - CalciMedica (NASDAQ:CALC)
Oppenheimer reiterates Outperform rating on CalciMedica stock ahead of key trial
CalciMedica partners with Telperian to use AI for clinical trial analysis